CX3CL1 (fractalkine) and its receptor CX3CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin

Journal of Experimental Medicine

Volumn 211, Issue 6, 2014, Pages 1185-1196

  Staumont Sallé, Delphine ^a,b,c,d,e   Fleury, Sébastien ^a,b,c,d   Lazzari, Anne ^f,g   Molendi Coste, Olivier ^a,b,c,d   Hornez, Nicolas ^c,e   Lavogiez, Céline ^c,e   Kanda, Akira ^a,b,c,d   Wartelle, Julien ^a,b,c,d   Fries, Anissa ^f,g   Pennino, Davide ^h   Mionnet, Cyrille ^f,g   Prawitt, Janne ^a,b,c,d   Bouchaert, Emmanuel ^a,b,c,d   Delaporte, Emmanuel ^e   Glaichenhaus, Nicolas ^f,g   Staels, Bart ^a,b,c,d   Julia, Valérie ^f,g   Dombrowicz, David ^a,b,c,d  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

^d France   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f CNRS   (France)

^g UNIVERSITÉ CÔTE D'AZUR   (France)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; EFFECTOR CELL; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PSORIASIS; SKIN SENSITIZATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CX3CL1; DERMATITIS, ATOPIC; FLOW CYTOMETRY; HUMANS; LUNG; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; OLIGONUCLEOTIDES; PROTEIN BINDING; RECEPTORS, CHEMOKINE; SKIN; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 84901757490     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121350     Document Type: Article

References (36)

1. Angeli, V., D. Staumont, A.S. Charbonnier, H. Hammad, P. Gosset, M. Pichavant, B.N. Lambrecht, M. Capron, D. Dombrowicz, and F. Trottein. 2004. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J. Immunol. 172:3822-3829. http:// dx.doi.org/10.4049/jimmunol.172.6.3822.
2. + dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA. 107:14745-14750. http://dx.doi.org/10.1073/pnas.1001562107.
3. Depner, M., M.S. Kormann, N. Klopp, T. Illig, C. Vogelberg, S.K. Weiland, E. von Mutius, C. Combadière, and M. Kabesch. 2007. CX3CR1 polymorphisms are associated with atopy but not asthma in German children. Int. Arch. Allergy Immunol. 144:91-94. http://dx.doi.org/10.1159/000102620.
4. Echigo, T., M. Hasegawa, Y. Shimada, K. Takehara, and S. Sato. 2004. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: Possible contribution to skin inflammation. J. Allergy Clin. Immunol. 113:940-948. http://dx.doi.org/10.1016/j.jaci.2004.02.030.
5. El-Shazly, A., P. Berger, P.O. Girodet, O. Ousova, M. Fayon, J.M. Vernejoux, R. Marthan, and J.M. Tunon-de-Lara. 2006. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J. Immunol. 176:1860-1868. http://dx.doi.org/10.4049/jimmunol.176.3.1860.
6. Fraticelli, P., M. Sironi, G. Bianchi, D. D'Ambrosio, C. Albanesi, A. Stoppacciaro, M. Chieppa, P. Allavena, L. Ruco, G. Girolomoni, et al. 2001. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest. 107:1173-1181. http://dx.doi.org/10.1172/JCI11517.
7. Geissmann, F., P. Revy, N. Brousse, Y. Lepelletier, C. Folli, A. Durandy, P. Chambon, and M. Dy. 2003. Retinoids regulate survival and antigen presentation by immature dendritic cells. J. Exp. Med. 198:623-634. http://dx.doi.org/10.1084/jem.20030390.
8. Grewe, M., C.A. Bruijnzeel-Koomen, E. Schöpf, T. Thepen, A.G. Langeveld-Wildschut, T. Ruzicka, and J. Krutmann. 1998. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today. 19:359-361. http://dx.doi.org/10.1016/S0167-5699(98)01285-7.
9. Guttman-Yassky, E., K.E. Nograles, and J.G. Krueger. 2011a. Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: clinical and pathologic concepts. J. Allergy Clin. Immunol. 127:1110-1118. http://dx.doi.org/ 10.1016/j.jaci.2011.01.053.
10. Guttman-Yassky, E., K.E. Nograles, and J.G. Krueger. 2011b. Contrasting pathogenesis of atopic dermatitis and psoriasis-part II: immune cell subsets and therapeutic concepts. J. Allergy Clin. Immunol. 127:1420-1432. http://dx.doi.org/10.1016/j.jaci.2011.01.054.
11. Hanifin, J.M., and G. Rajka. 1980. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. 59:44-47.
12. Homey, B., H. Alenius, A. Müller, H. Soto, E.P. Bowman, W. Yuan, L. McEvoy, A.I. Lauerma, T. Assmann, E. Bünemann, et al. 2002. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8:157-165. http://dx.doi.org/10.1038/nm0202-157.
13. H2 cells. Nat. Immunol. 12:167-177. http://dx.doi.org/10.1038/ni.1984.
14. Julia, V. 2012. CX3CL1 in allergic diseases: not just a chemotactic molecule. Allergy. 67:1106-1110. http://dx.doi.org/10.1111/j.1398-9995.2012.02870.x.
15. Jung, S., J. Aliberti, P. Graemmel, M.J. Sunshine, G.W. Kreutzberg, A. Sher, and D.R. Littman. 2000. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-4114. http://dx.doi.org/10.1128/ MCB.20.11.4106-4114.2000.
16. Kagami, S., T. Kakinuma, H. Saeki, Y. Tsunemi, H. Fujita, K. Nakamura, T. Takekoshi, M. Kishimoto, H. Mitsui, H. Torii, et al. 2003. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/ CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26. levels reflect the disease activity of atopic dermatitis. Clin. Exp. Immunol. 134:309-313. http://dx.doi.org/10.1046/j.1365-2249.2003.02273.x.
17. Kanda, A., V. Driss, N. Hornez, M. Abdallah, T. Roumier, G. Abboud, F. Legrand, D. Staumont-Sallé, S. Quéant, J. Bertout, et al. 2009. Eosinophil-derived IFN-γ induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes. J. Allergy Clin. Immunol. 124:573-582. http:// dx.doi.org/10.1016/j.jaci.2009.04.031.
18. Kim, K.W., A. Vallon-Eberhard, E. Zigmond, J. Farache, E. Shezen, G. Shakhar, A. Ludwig, S.A. Lira, and S. Jung. 2011. In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood. 118:e156-e167. http://dx.doi.org/10.1182/blood-2011-04-348946.
19. Landsman, L., L. Bar-On, A. Zernecke, K.W. Kim, R. Krauthgamer, E. Shagdarsuren, S.A. Lira, I.L. Weissman, C. Weber, and S. Jung. 2009. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood. 113:963-972. http://dx.doi.org/10.1182/ blood-2008-07-170787.
20. Lazarus, N.H., E.J. Kunkel, B. Johnston, E. Wilson, K.R. Youngman, and E.C. Butcher. 2003. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J. Immunol. 170:3799-3805. http://dx.doi.org/10.4049/jimmunol.170.7.3799.
21. Leung, D.Y., M. Boguniewicz, M.D. Howell, I. Nomura, and Q.A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113:651-657. http://dx.doi.org/10.1172/JCI21060.
22. Meucci, O., A. Fatatis, A.A. Simen, T.J. Bushell, P.W. Gray, and R.J. Miller. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA. 95:14500-14505. http://dx.doi.org/10.1073/pnas.95.24.14500.
23. Mikhak, Z., J.P. Strassner, and A.D. Luster. 2013. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J. Exp. Med. 210:1855-1869. http://dx.doi.org/ 10.1084/jem.20130091.
24. Mionnet, C., V. Buatois, A. Kanda, V. Milcent, S. Fleury, D. Lair, M. Langelot, Y. Lacoeuille, E. Hessel, R. Coffman, et al. 2010. CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat. Med. 16:1305-1312. http://dx.doi.org/ 10.1038/nm.2253.
25. Nakayama, T., Y. Watanabe, N. Oiso, T. Higuchi, A. Shigeta, N. Mizuguchi, F. Katou, K. Hashimoto, A. Kawada, and O. Yoshie. 2010. Eotaxin-3/ CC chemokine ligand 26 is a functional ligand for CX3CR1. J. Immunol. 185:6472-6479. http://dx.doi.org/10.4049/jimmunol.0904126.
26. Owczarek, W., M. Paplinska, T. Targowski, K. Jahnz-Rózyk, E. Paluchowska, A. Kucharczyk, and B. Kasztalewicz. 2010. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and nonlesional skin of patients with atopic dermatitis. Cytokine. 50:181-185. http://dx.doi.org/10.1016/j.cyto.2010.02.016.
27. Oyoshi, M.K., A. Elkhal, J.E. Scott, M.A. Wurbel, J.L. Hornick, J.J. Campbell, and R.S. Geha. 2011. Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin. J. Clin. Invest. 121:2210-2220. http://dx.doi.org/10.1172/JCI43586.
28. Reiss, Y., A.E. Proudfoot, C.A. Power, J.J. Campbell, and E.C. Butcher. 2001. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194:1541-1547. http://dx.doi.org/ 10.1084/jem.194.10.1541.
29. Schall, T.J., and A.E. Proudfoot. 2011. Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat. Rev. Immunol. 11:355-363. http://dx.doi.org/10.1038/nri2972.
30. Spergel, J.M., E. Mizoguchi, J.P. Brewer, T.R. Martin, A.K. Bhan, and R.S. Geha. 1998. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101:1614-1622. http://dx.doi.org/10.1172/JCI1647.
31. Spergel, J.M., E. Mizoguchi, H. Oettgen, A.K. Bhan, and R.S. Geha. 1999. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103:1103-1111. http://dx.doi.org/10.1172/JCI5669.
32. Staumont-Sallé, D., G. Abboud, C. Brénuchon, A. Kanda, T. Roumier, C. Lavogiez, S. Fleury, P. Rémy, J.P. Papin, J. Bertrand-Michel, et al. 2008. Peroxisome proliferator-activated receptor α regulates skin inflammation and humoral response in atopic dermatitis. J. Allergy Clin. Immunol. 121:962-968. http://dx.doi.org/10.1016/j.jaci.2007.12.1165.
33. Tremblay, K., M. Lemire, V. Provost, T. Pastinen, Y. Renaud, A.J. Sandford, M. Laviolette, T.J. Hudson, and C. Laprise. 2006. Association study between the CX3CR1 gene and asthma. Genes Immun. 7:632-639. http://dx.doi.org/10.1038/sj.gene.6364340.
34. van der Fits, L., S. Mourits, J.S. Voerman, M. Kant, L. Boon, J.D. Laman, F. Cornelissen, A.M. Mus, E. Florencia, E.P. Prens, and E. Lubberts. 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182:5836-5845. http://dx.doi.org/10.4049/jimmunol.0802999.
35. Wang, Q., L. Malherbe, D. Zhang, K. Zingler, N. Glaichenhaus, and N. Killeen. 2001. CD4 promotes breadth in the TCR repertoire. J. Immunol. 167:4311-4320. http://dx.doi.org/10.4049/jimmunol.167.8.4311.
36. + regulatory macrophages in mice. Blood. 119:3975-3986. http://dx.doi.org/10.1182/blood-2011-06-359315.